Investigation into the anti‐inflammatory properties of metformin in intervertebral disc cells

Abstract Introduction Intervertebral disc degeneration (IDD) is closely related to heightened inflammation in the annulus fibrosis (AF) and nucleus pulposus (NP) cells in the intervertebral disc. An imbalanced matrix homeostasis has been shown to contribute to disc degeneration and associated discog...

Full description

Bibliographic Details
Main Authors: Rahul Ramanathan, Ayesha Firdous, Qing Dong, Dong Wang, Joon Lee, Nam Vo, Gwendolyn Sowa
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:JOR Spine
Subjects:
Online Access:https://doi.org/10.1002/jsp2.1197
_version_ 1818218954925015040
author Rahul Ramanathan
Ayesha Firdous
Qing Dong
Dong Wang
Joon Lee
Nam Vo
Gwendolyn Sowa
author_facet Rahul Ramanathan
Ayesha Firdous
Qing Dong
Dong Wang
Joon Lee
Nam Vo
Gwendolyn Sowa
author_sort Rahul Ramanathan
collection DOAJ
description Abstract Introduction Intervertebral disc degeneration (IDD) is closely related to heightened inflammation in the annulus fibrosis (AF) and nucleus pulposus (NP) cells in the intervertebral disc. An imbalanced matrix homeostasis has been shown to contribute to disc degeneration and associated discogenic low back pain. Metformin, a diabetes medication, has been noted to exhibit anti‐inflammatory properties through upregulation of the AMPK pathway, leading to various anti‐inflammatory‐related responses in hepatocytes. However, it is still unclear how metformin influences disc cellular response to inflammatory stress and the corresponding mechanism. Hence, the objective of this study is to elucidate the effects of metformin on expression of key pro‐inflammatory, catabolic, and anabolic factors within rat AF cells in response to inflammatory stimulation and mechanical tensile stress. Methods Five Fischer 344 rats were sacrificed and their spines isolated. AF cells were cultured and plated in flexible silicone membrane‐based six‐well plates. Wells were split into eight groups and subjected to metformin, IL‐1β, mechanical stretch, and combined treatments. Relative gene expressions of MMP‐13, COX‐2, iNOS, AGC, and Col1 were assessed with quantitative real‐time polymerase chain reaction (qRT‐PCR), and downstream prostaglandin E2 (PGE2) production was quantified with enzyme‐linked immunosorbent assay (ELISA). NF‐kB nuclear translocation was also quantified. Results Metformin in the presence of the combined stress treatments (M + IL/S) significantly increased Col1, COX‐2, and MMP‐13 gene expression, decreased PGE2 production compared to IL/S conditions alone. Metformin treatment of cultured rat annulus fibrosus cells significantly reduced the nuclear translocation of NF‐κB after 4 h of IL‐1β treatment from 43.1% in case of IL‐1β treatment down to 26.2% in the case of metformin + IL‐1β treatment. Discussion The lack of metformin‐mediated suppression of inflammatory response in the nonstretch groups indicates that metformin may be enacting its effects through a stretch‐dependent manner. These results suggest a foundation for pursuing further research into metformin's potential role as an anti‐inflammatory agent for curtailing intervertebral disc degeneration.
first_indexed 2024-12-12T07:31:58Z
format Article
id doaj.art-ab51ba455bf54ad09aa14c2ba6e6ad3a
institution Directory Open Access Journal
issn 2572-1143
language English
last_indexed 2024-12-12T07:31:58Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series JOR Spine
spelling doaj.art-ab51ba455bf54ad09aa14c2ba6e6ad3a2022-12-22T00:33:00ZengWileyJOR Spine2572-11432022-06-0152n/an/a10.1002/jsp2.1197Investigation into the anti‐inflammatory properties of metformin in intervertebral disc cellsRahul Ramanathan0Ayesha Firdous1Qing Dong2Dong Wang3Joon Lee4Nam Vo5Gwendolyn Sowa6Ferguson Spine Laboratory, Department of Orthopaedic Surgery University of Pittsburgh Pittsburgh Pennsylvania USAFerguson Spine Laboratory, Department of Orthopaedic Surgery University of Pittsburgh Pittsburgh Pennsylvania USAFerguson Spine Laboratory, Department of Orthopaedic Surgery University of Pittsburgh Pittsburgh Pennsylvania USAFerguson Spine Laboratory, Department of Orthopaedic Surgery University of Pittsburgh Pittsburgh Pennsylvania USAFerguson Spine Laboratory, Department of Orthopaedic Surgery University of Pittsburgh Pittsburgh Pennsylvania USAFerguson Spine Laboratory, Department of Orthopaedic Surgery University of Pittsburgh Pittsburgh Pennsylvania USAFerguson Spine Laboratory, Department of Orthopaedic Surgery University of Pittsburgh Pittsburgh Pennsylvania USAAbstract Introduction Intervertebral disc degeneration (IDD) is closely related to heightened inflammation in the annulus fibrosis (AF) and nucleus pulposus (NP) cells in the intervertebral disc. An imbalanced matrix homeostasis has been shown to contribute to disc degeneration and associated discogenic low back pain. Metformin, a diabetes medication, has been noted to exhibit anti‐inflammatory properties through upregulation of the AMPK pathway, leading to various anti‐inflammatory‐related responses in hepatocytes. However, it is still unclear how metformin influences disc cellular response to inflammatory stress and the corresponding mechanism. Hence, the objective of this study is to elucidate the effects of metformin on expression of key pro‐inflammatory, catabolic, and anabolic factors within rat AF cells in response to inflammatory stimulation and mechanical tensile stress. Methods Five Fischer 344 rats were sacrificed and their spines isolated. AF cells were cultured and plated in flexible silicone membrane‐based six‐well plates. Wells were split into eight groups and subjected to metformin, IL‐1β, mechanical stretch, and combined treatments. Relative gene expressions of MMP‐13, COX‐2, iNOS, AGC, and Col1 were assessed with quantitative real‐time polymerase chain reaction (qRT‐PCR), and downstream prostaglandin E2 (PGE2) production was quantified with enzyme‐linked immunosorbent assay (ELISA). NF‐kB nuclear translocation was also quantified. Results Metformin in the presence of the combined stress treatments (M + IL/S) significantly increased Col1, COX‐2, and MMP‐13 gene expression, decreased PGE2 production compared to IL/S conditions alone. Metformin treatment of cultured rat annulus fibrosus cells significantly reduced the nuclear translocation of NF‐κB after 4 h of IL‐1β treatment from 43.1% in case of IL‐1β treatment down to 26.2% in the case of metformin + IL‐1β treatment. Discussion The lack of metformin‐mediated suppression of inflammatory response in the nonstretch groups indicates that metformin may be enacting its effects through a stretch‐dependent manner. These results suggest a foundation for pursuing further research into metformin's potential role as an anti‐inflammatory agent for curtailing intervertebral disc degeneration.https://doi.org/10.1002/jsp2.1197AMPK pathwayanti‐inflammatoryanti‐inflammatory therapybiomechanical profile of intervertebral discdisc agingdisc mechanics
spellingShingle Rahul Ramanathan
Ayesha Firdous
Qing Dong
Dong Wang
Joon Lee
Nam Vo
Gwendolyn Sowa
Investigation into the anti‐inflammatory properties of metformin in intervertebral disc cells
JOR Spine
AMPK pathway
anti‐inflammatory
anti‐inflammatory therapy
biomechanical profile of intervertebral disc
disc aging
disc mechanics
title Investigation into the anti‐inflammatory properties of metformin in intervertebral disc cells
title_full Investigation into the anti‐inflammatory properties of metformin in intervertebral disc cells
title_fullStr Investigation into the anti‐inflammatory properties of metformin in intervertebral disc cells
title_full_unstemmed Investigation into the anti‐inflammatory properties of metformin in intervertebral disc cells
title_short Investigation into the anti‐inflammatory properties of metformin in intervertebral disc cells
title_sort investigation into the anti inflammatory properties of metformin in intervertebral disc cells
topic AMPK pathway
anti‐inflammatory
anti‐inflammatory therapy
biomechanical profile of intervertebral disc
disc aging
disc mechanics
url https://doi.org/10.1002/jsp2.1197
work_keys_str_mv AT rahulramanathan investigationintotheantiinflammatorypropertiesofmetformininintervertebraldisccells
AT ayeshafirdous investigationintotheantiinflammatorypropertiesofmetformininintervertebraldisccells
AT qingdong investigationintotheantiinflammatorypropertiesofmetformininintervertebraldisccells
AT dongwang investigationintotheantiinflammatorypropertiesofmetformininintervertebraldisccells
AT joonlee investigationintotheantiinflammatorypropertiesofmetformininintervertebraldisccells
AT namvo investigationintotheantiinflammatorypropertiesofmetformininintervertebraldisccells
AT gwendolynsowa investigationintotheantiinflammatorypropertiesofmetformininintervertebraldisccells